Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NewSelf vs Queen RX

NewSelf
Graded #18

Higher grade

vs+19.599999999999994
Queen RX
Graded #212

Lower grade

The verdict

NewSelf takes it — 85.6/100 to 66/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNewSelf +17
93
76
Dose & formulationNewSelf +23
80
57
Clinical oversightNewSelf +15
84
69
Labs & monitoringNewSelf +29
82
53
FulfillmentNewSelf +12
87
75
Contract termsNewSelf +24
85
61
NewSelf · left barQueen RX · right bar

The numbers

MetricNewSelfQueen RX
WeighScore85.6/10066/100
GradeBC
Scorecard rank#18#212
Semaglutide$100/mo$100/mo (quarterly plan, compounded)
Tirzepatide$144/moNot disclosed
CoverageAll 50 states45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
NewSelf

Graded #18 · B

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history
Queen RX

Graded #212 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard